Clinical Trial Update: A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluated day-to-day changes in lung function in COPD patients taking albuterol (salbutamol) and ipratropium; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Albuterol (Salbutamol) (albuterol)
• Ipratropium (ipratropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2013-12-25